Two separate deals as I see it. 1) Zenith at the end of the year (assuming the science still is holding up) and 2) RVX..sometime in 2019 (assuming the end point that we’re looking for is realized...hopefully a well orchestrated bidding war.

So pleased that the share price is holding up over $3.00. First time in memory for me that we haven’t had a big drip, drip downward after some kind of significant PR...I think the FDA announcement was big (contingent on the end point happening)

Who knows about price...It will be what it will finally be.